The Pandemic Science Hub uses cutting edge science and collaborative clinical practice to find, develop and test effective treatments at speed. Pandemic Science Hub builds on Edinburgh University’s expertise in genetics alongside cutting-edge drug delivery robotics, sensing technologies and clinical trial methodologies to accelerate discoveries and clinical translation in lung diseases. Their ambition is to secure £100 million in investment and, through this funding, support collaborations with academic institutions, industry partners and global collaborators to drive interdisciplinary research and attract the best researchers to advance pandemic preparedness and treatment development. Pandemic Science Hub's website This article was published on 2025-08-04
